Global biopharma cold chain product sales 2016-2023

This statistic displays the predicted overall trend for biopharma cold chain product sales from 2016 to 2023. In 2019, it is expected that 338 billion U.S. dollars worth of biopharma cold-chain products will be sold globally. A general increase in cold-chain products is expected, likely due to the ongoing transition to bio-based products, rigorous preconditions of life science shipments linked with the growing globalization of the pharmaceutical trade. Cold-chain products require colder temperatures throughout the storage, handling, and transportation processes to maintain product integrity.

Global biopharma cold chain product sales from 2016 to 2023

Sales in billion U.S. dollars
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

April 2019



Survey time period

2016 to 2019

Supplementary notes

* Figures taken from a previous edition.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Cold chain logistics"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.